In-vivo imaging of meningeal inflammation in multiple sclerosis: Presence of evidence or evidence of presence?

@article{Kilsdonk2017InvivoIO,
  title={In-vivo imaging of meningeal inflammation in multiple sclerosis: Presence of evidence or evidence of presence?},
  author={Iris D. Kilsdonk and Menno Michiel Schoonheim and Mike P. Wattjes},
  journal={Multiple Sclerosis (Houndmills, Basingstoke, England)},
  year={2017},
  volume={23},
  pages={1169 - 1171}
}
Recent histopathology studies suggest the presence of meningeal inflammation in patients with multiple sclerosis (MS) that might be associated with subpial cortical demyelination and a rather worse disease course.1 Although a radiologist is not a pathologist, diagnostic neuroradiology aims to visualize and to detect almost every (subtle) pathological feature of a disease to its full extent. To be able to translate histopathological results into radiological images will create an opportunity to… 

Brain and Spinal Cord MRI in Multiple Sclerosis: an Update

Quantitative MRI methods and ultra-high-field MRI offer the opportunity for the quantitative assessment of damage in normal-appearing brain tissue, but the standardization of these techniques with the goal of implementation in clinical routine will be one of the major challenges in the near future.

Original Neuropsychological and magnetic resonance imaging (MRI) diagnos-tics in secondary progressive multiple sclerosis

The importance of cognitive testing and MRI for the prediction and detection of SPMS conversion is demonstrated and clinical, clinical, neuropsychological, and imaging vigilance allows stringent monitoring for neuroinflammatory and degenerative activity as well as treatment complica-tions.

Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis

This review aims to provide a comprehensive overview of the existing knowledge regarding the neuromodulatory function of macrophages and microglia in the healthy and injured CNS, and it discusses the feasibility of harnessingmicroglia and macrophage physiology to treat MS.

Zerebrale und spinale Bildgebung der Multiplen Sklerose: ein Update

Standardisierung dieser Techniken fur die MS-Diagnostik and Verlaufsbeobachtung zu den grosen Herausforderungen in der Zukunft zahlen, um damit diese vielversprechenden Methoden in die klinische Routine zu implementieren and zu etablieren.

Neuropsychologische und Magnetresonanztomographie(MRT)-Diagnostik bei sekundär progredienter Multipler Sklerose

Die Multiple Sklerose ist im longitudinalen Verlauf oft ein Krankheitskontinuum mit initial schubförmig-remittierender Phase (RRMS) und späterer sekundärer Progredienz (SPMS). Die meisten bisher

Imaging of meningeal inflammation should become part of the routine MRI protocol – No

LME on postcontrast T2-FLAIR is not sensitive to inflamed meningeal areas with a partially intact blood–meningeal barrier or in which gadolinium does not concentrate within the subarachnoid space, and does not appear to respond to treatments routinely used for MS.

References

SHOWING 1-10 OF 21 REFERENCES

Use of Magnetic Resonance Imaging to Visualize Leptomeningeal Inflammation in Patients With Multiple Sclerosis: A Review

The purpose of this review is to evaluate the current status and future prospects regarding the emerging role of magnetic resonance imaging to visualize leptomeningeal enhancement in patients with MS and place these findings in the proper pathobiologic and clinical context.

A “kissing lesion”: In-vivo 7T evidence of meningeal inflammation in early multiple sclerosis

This finding indicates that inflammatory infiltration into the cortex through the meninges underlies cortical pathology already in the early stage of disease and in mild disease course.

Investigation of leptomeningeal enhancement in MS

In contrast to intraparenchymal blood–brain barrier (BBB) dysfunction that is frequently seen in patients with MS, BBB dysfunction of leptomeningeal vessels is usually not detectable in Patients with early MS.

Seven‐tesla phase imaging of acute multiple sclerosis lesions: A new window into the inflammatory process

The potential of ultrahigh‐field magnetic resonance imaging (MRI; 7T), particularly phase imaging combined with dynamic contrast enhancement, to provide new insights in acute MS lesions is investigated.

Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis

Leptomeningeal contrast enhancement occurs frequently in MS and is a noninvasive, in vivo marker of inflammation and associated subpial demyelination, which might enable testing of new treatments aimed at eliminating this inflammation and potentially arresting progressive MS.

Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study

In this retrospective, pilot, observational longitudinal study, the presence of LM CE was associated with progression of cortical atrophy over 5 years.

Exploring the origins of grey matter damage in multiple sclerosis

Histological, immunological and neuroimaging studies have provided new insight in this rapidly expanding field, and form the basis of the most recent hypotheses on the pathogenesis of grey matter damage.

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

Data support an immunopathogenetic mechanism whereby B-cell follicles developing in the multiple sclerosis meninges exacerbate the detrimental effects of humoral immunity with a subsequent major impact on the integrity of the cortical structures.

Inflammatory cortical demyelination in early multiple sclerosis.

In this cohort of patients with early-stage multiple sclerosis, cortical demyelinating lesions were frequent, inflammatory, and strongly associated with meningeal inflammation.